Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AE.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AE.6ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
AE.6ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
AE.6ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
AE.6ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
AE.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AE.6SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AE.6SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
AE.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AE.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AE.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.6NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AE.6NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
AE.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AE.6NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AE.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AE.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AE.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AE.6NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AE.6ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
B.1.1.230ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.1.230ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.1.230ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.230ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.230ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.230ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
B.1.1.230ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.1.230SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.230SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.230SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.230EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.230EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.230ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.230ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.230NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.230NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.1.230NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.230NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.230NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.230NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.230NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.230NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.230ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
B.1.535ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.535ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.535ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.535ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.535ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.535ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used